The global lab automation market is projected to reach USD 5.20 billion by 2022 from USD 4.06 billion in 2017, at a CAGR of 5.1% during the forecast period. This market is fragmented in nature with a large number of regional and national players. In 2016, Tecan Group (Switzerland), PerkinElmer (US), Danaher (Beckman Coulter & Molecular Devices) (US), Thermo Fisher (US), Agilent Technologies (US), Eppendorf (Germany) were the top five players in the lab automation market and accounted for approximately 40% share of the overall market.
Tecan was the leading player in the global laboratory automation market in 2016. Tecan has maintained its footprint in the global lab automation market through continuous innovation and development of new products and their commercialization in different regions. The company also focuses on collaborations and acquisitions in order to expand its market share. The company acquired SPEware Corporation (US) and Pulssar Technologies (France) to enhance its presence in the market. Tecan has an extensive product portfolio for lab automation and further focuses on enhancing its presence in the market by adopting organic as well as inorganic growth strategies.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1158
In 2016, PerkinElmer ranked second in the global lab automation market. It is engaged in providing technologies, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets. The company has a robust product portfolio for lab automation. The company focuses on offering new and technologically advanced innovative products through their brands Zephyr, JANUS, and Twister. To further enhance its product portfolio, the company launched complimentary advanced software solutions such as ChemBioOffice software suite in June 2014. In line with its efforts to provide complementary software to its automation platforms, PerkinElmer, in 2015, collaborated with Waters Corporation (US), a provider innovative lab automation software. In February 2016, the company launched the LabChip NGS 3K assay for the current interest fields of genomics research, cancer research, drug development, and next-generation sequencing. A blend of organic and inorganic strategies has enabled the company to maintain its leading position in the laboratory automation market.
Thermo Fisher Scientific held the third position in the market in 2016. The company geographically operates in over 150 countries globally. The company has focused on strengthening its market presence by acquiring leading lab automation technology providers. In 2017, Thermo Fisher acquired Patheon N.V. (Netherlands), Core Informatics (US), and Finesse Solutions, Inc. (US). These acquisitions were aimed at technically strengthening its lab automation portfolio through the integrated solutions offered by these companies. Furthermore, in August 2016, Thermo Fisher partnered with Hamilton Bonaduz AG (Switzerland) to distribute automation platforms and reagents to forensic customers in Europe, the Middle East, Africa, and China. Thermo Fisher also launched SampleManager, an integrated lab management solution involving laboratory information management (LIMS), scientific data management (SDMS), and lab execution system (LES); Varioskan LUX, a multimode microplate reader; Lab Execution System (LES); and Thermo Scientific iAutomate software, an online automation configuration tool in the past three years.
Other prominent players in the market include Agilent Technologies, Inc. (Agilent) (US), Hamilton Robotics (US), QIAGEN N.V. (QIAGEN) (Netherlands), Roche Diagnostics (Roche) (Switzerland), and Siemens Healthcare (Siemens) (Germany).
